New collaboration aims to break through LGMD treatment barriers

Critical Path Institute (C-Path) today announced the formation of a new task force under its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®), dedicated to advancing therapeutic development for limb-girdle muscular dystrophies (LGMDs).

DaVita, Google Cloud to Develop Customized Clinical OS to Transform Kidney Care

What You Should Know: – DaVita Inc. and Google Cloud are teaming up to create a new clinical operating system that sets a foundation for

October 20, 2023

Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval – Pharmaceutical Technology

Imvanex generated revenue of $730m for Bavarian Nordic in 2023. Image credit: Shutterstock/ davide bonaldo. The European Medicines Agency’s Committee for Medicinal Products for Human

July 26, 2024

Effective Treatments Identified for Pediatric Complication of COVID

PHOENIX — First-line treatment with methylprednisolone and second-line treatment with tocilizumab (Actemra) shortened hospital stays for children with pediatric multisystem inflammatory syndrome temporally associated with

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.